Oral Contraceptive Pills Market Technology, Scope, Assessment, Capacity, Current Status And Forecast 2023-2032|Teva Pharmaceutical Industries Ltd., Bayer AG, Syzygy Healthcare, Mankind Pharma Ltd., Pfizer Inc.

The Oral Contraceptive Pills Global Market Report 2023 by The Business Research Company, provides oral contraceptive pills market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Oral Contraceptive Pills Market:

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

According to The Business Research Company’s Oral Contraceptive Pills Global Market Report 2023, the market size is expected to grow from$20.13 billion in 2022 to $21.61 billion in 2023 at a compound annual growth rate (CAGR) of 7.35%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of oral contraceptive pills is expected to grow to $36.09 billion in 2027 at a CAGR of 13.68%.

The high incidence of unintended pregnancies is expected to drive the growth of the oral contraceptive pills market over the coming years. Unintended pregnancy is a pregnancy that is always unwanted, such as a pregnancy where no children have been planned. The University of California, San Francisco (UCSF) study shows that the rates of unwanted pregnancy and abortion declined substantially when women received a one-year prescription of oral contraceptives.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=3900&type=smp

The oral contraceptive pills market is segmented:

1) By Type: Combination, Progestin Only, Other Types

2) By Category: Generic, Branded

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels

Major institutes and companies operating in the oral contraceptive pill sector are focusing on developing innovative solutions for oral contraceptive pills. For instance, in July 2022, HRA Pharma, a France based innovative healthcare company, developed an over the-counter birth control pill called “”Opill.”” HRA Pharma has submitted an application to the Food and Drug Administration in the United States. Opil is a progestin-based contraceptive that helps people access contraception without facing any difficulty.

The oral contraceptive pills market report table of contents includes: